FOIA: OHRP Investigation – Brigham and Woment’s Hospital
FOIA: OHRP Investigation – Brigham and Women’s Hospital
Letter page one:
Letter page 2:

Letter page 3:

Letter page one:

Letter page 2:

Letter page 3:

Serono to pay $704 million for Illegal Marketing AIDS drug and “voodoolike” clinical trials – NYT Thu, 20 Oct 2005 Another scandal involving corrupt criminal marketing by a bio-pharmaceutical company that illegally marketed an AIDS test and drug by enlisting physicians to prescribe its drug. The New York Times reports…
CNN / Mercury News: Bioshield Vaccine Contracts to mfg with “closest ties with the government” Sun, 18 Sep 2005 Questions are being raised (again) about the government vaccine purchasing program, ostensibly as a measure to protect the American public in the event of a bioterrorist attack. Mercury News (Twin City,…
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004 The Washington Post examines FDA’s record of surveillance and the evidence is clear: since 1992 when Congress required drug companies to pay users fees to the FDA, the agency’s focus changed from safety…
"OHRP shared your concerns and discussed them with the National Heart Lung and Blood Institute. They appreciated the concerns and have revised the protocol to address them."
’91 Merck Memo Warned of Mercury in Baby Vaccines – LAT Tue, 8 Feb 2005 The Los Angeles Times reports that a 1991 internal Merck memo obtained from a whistleblower by James Moody, a Washington lawyer who works with parent groups on vaccine safety issues, provides the “first hard evidence…
Charitable Choice: Research Grants–Juvenile Diabetes Research Foundation – National Journal Tue, 8 Mar 2005 The Washington Post reports that conservatives have crafted a “bioethics agenda” on cloning and stem cell research. Such an agendaq determines what research the government will and will not fund. http://www.washingtonpost.com/wp-dyn/articles/A15569-2005Mar7.html Below is an excerpt of…